Nail changes associated with chemotherapy in children

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 2, 2007, Pages 186-190

  Chen, W ^a   Yu, Y S ^a   Liu, Y H ^a   Sheen, J M ^b   Hsiao, C C ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Leuconychia; Muehrcke's line; Nail

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; RETINOIC ACID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENAL TUMOR; ALVEOLAR SOFT PART SARCOMA; ARTICLE; BACTERIAL INFECTION; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLEAR CELL SARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FINGERNAIL ONYCHOMYCOSIS; GERM CELL TUMOR; HUMAN; HYPOALBUMINEMIA; KIDNEY SARCOMA; MALE; MYELOMONOCYTIC LEUKEMIA; NAIL DISEASE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NONHODGKIN LYMPHOMA; PINEAL BODY TUMOR; PRIORITY JOURNAL; RETINOBLASTOMA; RHABDOMYOSARCOMA; SKIN MANIFESTATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; NAIL DISEASES;

EID: 33846342599     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01887.x     Document Type: Article

References (15)

1. Daniel CR III, Scher RK. Nail changes secondary to systemic drugs or ingestants. J Am Acad Dermatol 1984; 10: 250-258.
2. Chen GY, Chen YH, Hsu MM, Tsao CJ, Chen WC. Onychomadesis and onycholysis associated with capecitabine. Br J Dermatol 2001; 145: 521-522.
3. Minisini AM, Tosti A, Sobrero AF et al. Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 2003; 14: 333-337.
4. Rafi L, Friedrich M, Tilgen W, Reichrath J. Severe nail changes due to docetaxel treatment. Eur J Dermatol 2003; 13: 610-611.
5. Leonard GD, Zujewski JA. Docetaxel-related skin, nail, and vascular toxicity. Ann Pharmacother 2003; 37: 148.
6. Tinio P, Bershad S, Levitt JO. Medical pearl: Docetaxel-induced onycholysis. J Am Acad Dermatol 2005; 52: 350-351.
7. Bean WB. Nail growth: 30 years of observation. Arch Intern Med 1974; 134: 497-502.
8. Lavelle C. The effect of age on the rate of nail growth. J Gerontol 1968; 23: 557-559.
9. Yoruk A, Yukselgungor H. Chemotherapy induced transverse leukonychia in children. Int J Dermatol 2003; 42: 468-469.
10. Shelley WB, Humphrey GB. Transverse leukonychia (Mees'lines) due to daunorubicin chemotherapy. Pediatr Dermatol 1997; 14: 144-145.
11. James WD, Odom RB. Chemotherapy-induced transverse white lines in the fingernails. Arch Dermatol 1983; 119: 334-335.
12. Schwartz RA, Vickerman CE. Muehrcke's lines of the fingernails. Arch Intern Med 1979; 139: 242.
13. Baran R, Tosti A. Nails. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine, 6th edn. McGraw-Hill, New York, 2003: 656-671.
14. Braun-Falco O, Plewig G, Wolff HH. Dermatologie und Venerologie. Springer-Verlag, Berlin, 1996.
15. Chen GY, Chen W, Huang WT. Single transverse apparent leukonychia caused by 5-fluorouracil plus leucovorin. Dermatology 2003; 207: 86-87.